Ignite Creation Date:
2025-12-24 @ 2:19 PM
Ignite Modification Date:
2026-01-02 @ 3:22 AM
Study NCT ID:
NCT03914495
Status:
TERMINATED
Last Update Posted:
2023-02-13
First Post:
2019-04-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Role of Microbiome Reprogramming on Liver Fat Accumulation
Sponsor:
AdventHealth Translational Research Institute
Organization:
Study Overview
Official Title:
The Role of Microbiome Reprogramming on Liver Fat Accumulation
Status:
TERMINATED
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
PI carefully considered multiple factors and decided to close study to any further enrollment.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MILE
Brief Summary:
The purpose of this study is to investigate whether reprogramming the microbiome via soluble fiber supplementation will decrease liver fat in obese individuals.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: